Thanh Erion

Thanh Erion currently serves as Senior Director of Intellectual Property at AbbVie, a position held since February 2024, following a similar role at ImmunoGen, Inc. from September 2015 to February 2024. Erion excels in designing worldwide patent strategies, managing significant IP commercial activities, and guiding direct reports within the field. With prior experience at Clark & Elbing LLP as a Senior Patent Agent and Technology Specialist, as well as academic experience from Yale University, Erion possesses a strong background in molecular biophysics and biochemistry, further complemented by a JD from Suffolk University Law School and a BS in Chemistry from UC Irvine.